Y Zheng — Endo Lab

rct 2026

[Efficacy and safety of triptorelin acetate microspheres for injection versus triptorelin acetate for injection in Chinese patients with endometriosis: a multicenter, randomized, double-blind, phase Ⅲ non-inferiority clinical trial]

Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20250421-00161

Objective: To evaluate the efficacy and safety of triptorelin acetate microspheres for injection compared with triptorelin acetate for injection in the treatment of endometriosis. Methods: A total of 392 patients with endometriosis were pro…

2022

8661 Identification of Distinct Pathways in Ovarian Endometrioma and Deep Endometriosis

·doi:10.1016/j.jmig.2022.09.456

2022

8795 Impact of Surgical Procedures on Intestinal Function and Quality of Life in Patients with Deep Endometriosis: A Prospective Study

·doi:10.1016/j.jmig.2022.09.486

lab-animal 2022

Peer Review #3 of "BMSC-derived exosomal miR-27a-3p and miR-196b-5p regulate bone remodeling in ovariectomized rats (v0.1)"

·doi:10.7287/peerj.13744v0.1/reviews/3

Background.In the bone marrow microenvironment of postmenopausal osteoporosis (PMOP), bone marrow mesenchymal stem cell (BMSC)-derived exosomal miRNAs play an important role in bone formation and bone resorption, although the pathogenesis h…

2019

1907 Hydronephrosis- Ureteral Squeezed by Deep Infiltrating Endometriosis Lesions

·doi:10.1016/j.jmig.2019.09.355

2016

Analysis of Predictive Factors for Recurrence of Deep Infiltrating Endometriosis: A 2-Year Prospective Study

·doi:10.1016/j.jmig.2016.08.169

2016

Reproductive Outcome in Postoperative Deep Infiltrating Endometriosis

·doi:10.1016/j.jmig.2016.08.072

other 2015

Analysis of Risk Factors for Post-Operative Rectovaginal Fistula in Deep Endometriosis

Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2015.08.151

2011

Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice

·doi:10.1093/humrep/der173

other 2008

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel

British journal of cancer ·doi:10.1038/sj.bjc.6604630

Currently, there are no effective biomarkers for ovarian cancer prognosis or prediction of therapeutic response. The objective of this study was to examine a panel of 10 serum biochemical parameters for their ability to predict response to …